https://orcid.org/0000-0002-0200-3390
References
- Yoon HJ, Lee DH, Ok Kim S, et al. Acne erythema improvement by long‐pulsed 595‐nm pulsed‐dye laser treatment: a pilot study. J Dermatol Treat. 2008;19(1):38–44.
- Min S, Park SY, Yoon JY, et al. Fractional microneedling radiofrequency treatment for acne-related post-inflammatory erythema. Acta Derm Venereol. 2016;96(1):87–91.
- Mathew ML, Karthik R, Mallikarjun M, et al. Intense pulsed light therapy for acne-induced post-inflammatory erythema. Indian Dermatol Online J. 2018;9(3):159.
- Erceg A, de Jong EM, van de Kerkhof PC, et al. The efficacy of pulsed dye laser treatment for inflammatory skin diseases: a systematic review. J Am Acad Dermatol. 2013;69(4):609.e8–615.e8.
- Civantos Calzada B, Aleixandre de Artiñano A. Aleixandre de Artinñano A. alpha-adrenoceptor subtypes. Pharmacol Res. 2001;44(3):195–208.
- Shanler SD, Ondo AL. Successful treatment of the erythema and flushing of rosacea using a topically applied selective alpha1-adrenergic receptor agonist, oxymetazoline. Arch Dermatol. 2007;143(11):1369–1371.
- Beck-Speier I, Dayal N, Karg E, et al. Oxymetazoline inhibits proinflammatory reactions: effect on arachidonic acid-derived metabolite. J Pharmacol Exp Ther. 2006;316(2):843–851.
- Chalothorn D, McCune DF, Edelmann SE, et al. Differences in the cellular localization and agonist-mediated internalization properties of the alpha(1)-adrenoceptor subtypes. Mol Pharmacol. 2002;61(5):1008–1016.
- Manosroi A, Podjanasoonthon K, Manosroi J. Stability and release of topical tranexamic acid liposome formulations. J Cosmet Sci. 2002;53(6):375–386.
- Tan J, Liu H, Leyden J, et al. Reliability of clinician erythema assessment grading scale. J Am Acad Dermatol. 2014;71(4):760–763.
- Khan R, Hanbury A, Stöttinger J, et al. Colour based skin classification. Pattern Recog Lett. 2012;33(2):157–163.
- Kirkpatrick LA, Feeney BC, A simple guide to IBM SPSS statistics for version 20.0. Student ed. Belmont, Calif.: Wadsworth, Cengage Learning; 2013.
- Park KY, Ko EJ, Seo SJ, et al. Comparison of fractional, nonablative, 1550-nm laser and 595-nm pulsed dye laser for the treatment of facial erythema resulting from acne: a split-face, evaluator-blinded, randomized pilot study. J Cosmet Laser Ther. 2014;16(3):120–123.
- Draelos ZD, Gold MH, Weiss RA, et al. Efficacy and safety of oxymetazoline cream 1.0% for treatment of persistent facial erythema associated with rosacea: findings from the 52-week open label REVEAL trial. J Am Acad Dermatol. 2018;78(6):1156–1163.
- Gold MH, Lebwohl M, Biesman BS, et al. Daily oxymetazoline cream demonstrates high and sustained efficacy in patients with persistent erythema of rosacea through 52 weeks of treatment. J Am Acad Dermatol. 2018;79(3):e57–e59.
- Rasha MG. Topical brimonidine tartrate as a novel treatment for facial erythema of rosacea and acne erythema. J Egypt Women Dermatol Soc. 2016;13:55–64.
- Jakhar D, Kaur I. Topical 5% Tranexamic acid for acne-related post inflammatory erythema. J Am Acad Dermatol. 2020;82(6):e187–e188.
- Abdelrazik H. Combination of skin micro-needling and topical application of tranexamic acid and vitamin C: new clinical application: a pilot study for treatment of persistent post acne erythema: 2742. J Am Acad Dermatol. 2016;74(5):AB4.